Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples